In vitro effects of estrogens on rat prostatic 5 alpha-reduction of testosterone.
D000085:Acetates; D000818:Animals; D002250:Carbon Radioisotopes; D004958:Estradiol / Q000494:pharmacology; D004964:Estriol / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology*; D004970:Estrone / Q000494:pharmacology; D004987:Ethers; D005965:Glucuronates; D007700:Kinetics; D008297:Male; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D010710:Phosphates; D011467:Prostate / Q000187:drug effects / Q000201:enzymology*; D051381:Rats; D013329:Structure-Activity Relationship; D013386:Succinates; D013464:Sulfuric Acids; D013739:Testosterone / Q000378:metabolism*; D014316:Tritium; D014631:Valerates
D000085:Acetates; D002250:Carbon Radioisotopes; D004967:Estrogens; D004987:Ethers; D005965:Glucuronates; D010710:Phosphates; D013386:Succinates; D013464:Sulfuric Acids; D014631:Valerates; D014316:Tritium; D004970:Estrone; D013739:Testosterone; D004958:Estradiol; D010088:Oxidoreductases; D004964:Estriol